Data / Form D filings / WELLESLEY PHARMACEUTICALS LLC
WELLESLEY PHARMACEUTICALS LLC: Form D filings
WELLESLEY PHARMACEUTICALS LLC, a pharmaceuticals company in Newtown, PA, filed 4 Form D notices with the SEC between 2015 and 2017. The latest, on October 13, 2017, reports $3.8 million sold of a $5.8 million offering to 14 investors.
Find out what WELLESLEY PHARMACEUTICALS LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3 VALLEY VIEW DRIVE, Newtown, PA, 18940
- Phone
- (215) 493-0168
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1634861
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 13, 2017 | Amendment | $5,777,581 | $3,777,581 | $2,000,000 | 14 | Mar 28, 2015 | sec.gov |
| Feb 3, 2017 | Amendment | $2,800,000 | $348,376 | $2,451,624 | 9 | Mar 28, 2015 | sec.gov |
| Apr 20, 2016 | New notice | $2,300,000 | $298,377 | $2,001,623 | 8 | Mar 28, 2015 | sec.gov |
| Feb 27, 2015 | New notice | $3,400,000 | $934,902 | $2,465,098 | 18 | Jul 7, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Alan Lineberry | Director | |
| Candan Alan Karabagli | Director | |
| Omer Alan Karahan | Director | |
| David Alan Dill | Executive Officer, Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
Every Form D from the week of Oct 9, 2017 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what WELLESLEY PHARMACEUTICALS LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.